Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase)

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 69-75

  Traver, R D ^a,b   Siegel, D ^b   Beall, H D ^b   Phillips, R M ^c   Gibson, N W ^a,d   Franklin, W A ^b   Ross, D ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

^d PFIZER INC   (United States)

Author keywords

Chemoprevention; Chemotherapy; DT diaphorase; NAD(P)H:quinone oxidoreductase; Polymorphism

Indexed keywords

MESSENGER RNA; MUTANT PROTEIN; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ENZYME STRUCTURE; ESCHERICHIA COLI; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRUCTURE ACTIVITY RELATION;

EID: 0031021280     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.11     Document Type: Article

References (40)

1. Beall HD, Mulcahy RT, Siegel D, Traver RD, Gibson NW and Ross D (1994) Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases. Cancer Res 54: 3196-3201
2. Benson A, Hunkeler MJ and Talalay P (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77: 5216-5220
3. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Biochemistry 72: 248-254
4. Caporaso N, Landi MT and Vineis P (1991) Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics 1:4-19
5. Edwards YH, Potter J, and Hopkinson DA (1980) Human FAD-dependent NAD(P)H diaphorase. Biochem J 187: 429-436
6. Eickelmann P, Ebert T, Warskulat U, Schulz WA and Sies H (1994a) Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis 15: 219-225
7. Eickelmann P, Schulz WA, Ronde D, Schmitz-Drager B and Sies H (1944b) Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol Chem Hoppe-Seyler 375: 439-445
8. Enger PA, Kensler TW, Prestera T, Talalay P, Libby AH, Joyner HH and Curhey TJ (1994) Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis 15: 177-181
9. Ernster L (1967) DT-Diaphorase. Methods Enzymol 10: 309-317
10. Faeder EJ and Siegel LM (1973) A rapid micromethod for determination of FMN and FAD in mixtures. Anal Biochem 53: 332-336
11. Ganousis LG, Goon D, Zyglewska T, Wu KK and Ross D (1992) Cell-specific metabolism in mouse bone marrow stroma. Studies of activation and detoxification of benzene metabolites. Mol Pharmacol 42: 531-536
12. Gibson NW, Hartley JA, Butler J, Siegel D and Ross D (1992) Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol Pharmacol 42: 531-536
13. Gibson NW, Phillips RM and Ross D (1994) Mitomycin C. Cancer Chemother Biol Response Modifiers 15: 51-57
14. Gonzalez FJ and Idle JR (1994) Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin Pharmacokinet 26: 59-70
15. Jaiswal AK (1991) Human NAD(P)H:quinone oxidoreductase (NQOI) gene structure and induction by dioxin. Biochemistry 30: 10647-10653
16. Jaiswal KA, Mcbride OW, Adesnik M and Nebert DW (1988) Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J Biol Chem 263: 13572-13578
17. Kuehl BL, Paterson JWE, Peacock JW, Paterson MC, and Rauth AM (1995) Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 72: 555-561
18. Kolesar JM, Burris HA and Kuhn JG (1995) Re: detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Inst 87: 1022-1024
19. LI R, Bianchet MA, Talalay P and Amzel LM (1995) The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprevention and chemotherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci USA 92: 8846-8850
20. MA Q, CUI K, Xiao F, LU Ayh and Yang CS (1992) Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis. J Biol Chem 267: 22298-22304
21. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD and Ross D (1992) Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res 52: 4752-4757
22. Marshall RS, Paterson MC and Rauth AM (1991a) DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family. Carcinogenesis 12: 1175-1180
23. Marshall RS, Paterson MC and Rauth AM (1991b) Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual. Biochem Pharmacol 41: 1351-1360
24. Peppel K and Baglioni C (1990) A simple and fast method to extract RNA from tissue culture cells. Biotechniques 9: 711-713
25. Phillips RM, Sarang M and Gibson NW (1993) Semi-quantitative measurement of gene expression byRT-PCR: a cautionary tale. Int J Oncol 3: 1097-1102
26. Prochaska HJ, Santamaria AB and Talalay P (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci USA 89: 2394-2398
27. Ross D, Siegel D, Gibson NW, Pacheco D, Thomas DJ, Reasor M and Wierda D (1990) Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Rad Res Commun 8: 373-381
28. Ross D, Siegel D, Beall HD, Prakash AS, Mulcahy RT and Gibson NW (1993) DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of milomycin C. Cancer Metast Rev 12: 83-101
29. Ross D, Traver RD, Siegel D, Kuehl BL, Misra V and Rauth AM (1996) A polymorphism in NAD(P)H: quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer 74: 995-996
30. Rosvold EA, Mcglynn KA, Lustbader ED and Buetow KH (1995a) Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics 5: 199-206
31. Rosvold EA, Mcglynn KA, Lustbader ED and Buetow KH (1995b) Re: detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer. J Natl Cancer Ins 87: 1022-1024
32. Rothman N, Traver RD, Smith MT, Hayes RB, LI GL, Campleman S, Dosemecci M, Zhang L, Linet M, Wacholder S, Yin SN and Ross D (1996) Lack of NAD(P)H:quinone oridoreductase activity (NQO1) is associated with increased risk of benzene hematotoxicity. Proc Am Assoc Cancer Res 37: 258
33. Schlager JJ and Powis G (1990) Cytosolic NAD(P)H:(quinone-acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 45: 403-409
34. Siegel D, Gibson NW, Preusch, PC and Ross D (1990) Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50: 7483-7489
35. Sharkis DH and Swenson RP (1989) Purification by cibacron blue F3GA dye affinity chromatography and comparison of NAD(P)H:quinone reductase (E.C.I.6.99.2) from rat liver cytosol and microsomes. Biochem Biophys Res Commun 161:434-441
36. Traver RD, Horikoshi T, Danenberg KD, Stadlbauer THW, Danenberg PV, Ross D and Gibson NW (1992) NAD(P)H:quinone oxidoreductase gene expression in humun colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 52: 797-802
37. Traver RD, Phillips RM, Gibson NW and Ross D (1995) A point mutation in both human lung and colon carcinoma cell lines leading to a loss of DT-diaphorase activity. Proc Am Assoc Cancer Res 36: 525
38. Walton MI and Workman P (1990) Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin. Biochem Pharmacol 39: 1735-1742
39. Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45: 1-8
40. Zhang Y, Talalay P, Cho CG and Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89: 2399-2403